학술논문
Risk of requiring a walking aid after 6.5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis: Data from the OPERA I and OPERA II trials
Document Type
Article
Author
Source
In: European Journal of Neurology . (European Journal of Neurology, April 2022, 29(4):1238-1242)
Subject
Language
English
ISSN
14681331
13515101
13515101